| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
| 2013 | A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1). | Ramalingam, Suresh S; ...; Andric, Zoran G   ; ...; Zaric, Bojan ; ...; Vukovic, Vojislav M; ...; (broj, koautora 20) | Konferencijski rad | |
| 2014 | Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. | Ramalingam, Suresh S; Zaric, Bojan ; Ceric, Timur; ...; Samarzija, Miroslav; ...; Vukovic, Vojislav M; (broj, koautora 20) | Konferencijski rad | |
| 2013 | GALAXY-2 trial: A randomized phase III study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced non-small cell lung adenocarcinoma. | Fennell, Dean Anthony; ...; Vukovic, Vojislav M; ...; (broj, koautora 17) | Konferencijski rad | |
| 2012 | Quality of Life Analysis in the Galaxy Trialtm (Nct01348126): a Randomized Phase Iib/Iii Study of Ganetespib (Sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Patients with Stage Iiib Or Iv Nsclc | Andric, Zoran G ; Havel, L; Di, Hariry I; Vukovic, Vojislav M; Teofilovici, F; Guo, W; Mulcahey, S; Bradley, R; Ceric, Timur | Konferencijski rad | |